cyclohexanol has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braida, D; Sala, M | 1 |
| Hunt, GE; Li, KM; Mallet, PE; McGregor, IS; Morley, KC | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Clark, RF; Gerona, RR; Lo, J; Thornton, SL; Wu, AH | 1 |
4 other study(ies) available for cyclohexanol and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.
Topics: Animals; Cannabinoid Receptor Modulators; Cannabinoids; Conditioning, Operant; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Fatty Acids, Unsaturated; Hallucinogens; Injections, Intraventricular; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reinforcement, Psychology; Rimonabant; Self Administration | 2002 |
Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats.
Topics: Animals; Cannabinoids; Cyclohexanols; Fever; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Serotonin | 2004 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.
Topics: Adolescent; Cannabinoids; Cyclohexanols; Designer Drugs; Drug Interactions; Drug Therapy, Combination; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phenols; Piperidines; Psychoses, Substance-Induced; Substance Abuse Detection | 2012 |